Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pretta

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Expert Opinion on Therapeutic Targets|November 22, 2021
Uncovering key targets of success for immunotherapy in pancreatic cancerAndrea Pretta, Eleonora Lai, Mara Persano, et al.
Cancer Treatment Reviews|November 19, 2019
New therapeutic targets in pancreatic cancerEleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Cancers|September 29, 2020
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN TrialSilvia Camera, Tugba Akin Telli, Erwin Woff, et al.
Frontiers in Oncology|May 9, 2022
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer PatientsStefano Mariani, Marco Puzzoni, Riccardo Giampieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2024
Early taxane exposure and neurotoxicity in breast cancer patientsErika Cimbro, Mariele Dessì, Pina Ziranu, et al.
Therapeutic Advances in Medical Oncology|February 26, 2026
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancerAndrea Pretta, Riccardo Giampieri, Pina Ziranu, et al.
Targeted Oncology|May 10, 2021
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line TreatmentPina Ziranu, Eleonora Lai, Marta Schirripa, et al.
Acta Oncologica (Stockholm, Sweden)|August 22, 2020
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panelGiacomo Bregni, Tiberio Sticca, Silvia Camera, et al.
Critical Reviews in Oncology/Hematology|December 3, 2020
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?Eleonora Lai, Giorgio Astara, Pina Ziranu, et al.
Tumori|November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitusAndrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Expert Opinion on Therapeutic Targets|November 22, 2021
Uncovering key targets of success for immunotherapy in pancreatic cancerAndrea Pretta, Eleonora Lai, Mara Persano, et al.
Cancer Treatment Reviews|November 19, 2019
New therapeutic targets in pancreatic cancerEleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Cancers|September 29, 2020
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN TrialSilvia Camera, Tugba Akin Telli, Erwin Woff, et al.
Frontiers in Oncology|May 9, 2022
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer PatientsStefano Mariani, Marco Puzzoni, Riccardo Giampieri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2024
Early taxane exposure and neurotoxicity in breast cancer patientsErika Cimbro, Mariele Dessì, Pina Ziranu, et al.
Therapeutic Advances in Medical Oncology|February 26, 2026
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancerAndrea Pretta, Riccardo Giampieri, Pina Ziranu, et al.
Targeted Oncology|May 10, 2021
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line TreatmentPina Ziranu, Eleonora Lai, Marta Schirripa, et al.
Acta Oncologica (Stockholm, Sweden)|August 22, 2020
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panelGiacomo Bregni, Tiberio Sticca, Silvia Camera, et al.
Critical Reviews in Oncology/Hematology|December 3, 2020
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?Eleonora Lai, Giorgio Astara, Pina Ziranu, et al.
Tumori|November 27, 2020
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitusAndrea Pretta, Pina Ziranu, Marco Puzzoni, et al.
Pageof 6